We are live on ! Find out more
BRM

Boston Research & Management Portfolio holdings

AUM $421M
1-Year Est. Return 16.18%
This Fund
S&P 500
This Quarter Est. Return
+7.29%
1 Year Est. Return
+16.18%
3 Year Est. Return
+48.21%
5 Year Est. Return
+65.09%
10 Year Est. Return
+242.1%
AUM
$199M
AUM Growth
+$3.73M
Cap. Flow
-$8.84M
Cap. Flow %
-4.43%
Top 10 Hldgs %
24.27%
Holding
98
New
2
Increased
5
Reduced
64
Closed
1

Sector Composition

Rank Sector Weight
1 Industrials 14.54%
2 Technology 13.69%
3 Financials 12.39%
4 Healthcare 11.03%
5 Consumer Staples 10.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OIH icon
51
VanEck Oil Services ETF
OIH
$2.06B
$1.43M 0.72%
2,745
-74
-3% -$36.7K
T icon
52
AT&T
T
$167B
$1.39M 0.69%
47,190
-6,496
-12% -$177K
JNJ icon
53
Johnson & Johnson
JNJ
$641B
$1.37M 0.69%
9,805
-700
-7% -$97.5K
CVX icon
54
Chevron
CVX
$378B
$1.2M 0.6%
9,592
-1,110
-10% -$132K
GOOG icon
55
Alphabet (Google) Class C
GOOG
$3.99T
$1.11M 0.56%
21,240
-3,120
-13% -$159K
AMJ
56
DELISTED
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
$1.07M 0.54%
38,950
+310
+0.8% +$8.41K
JPM icon
57
JPMorgan Chase
JPM
$947B
$946K 0.47%
8,853
-100
-1% -$10.1K
IAU icon
58
iShares Gold Trust
IAU
$63.4B
$914K 0.46%
36,555
-2,900
-7% -$71.2K
CTAS icon
59
Cintas
CTAS
$84.4B
$861K 0.43%
22,120
-3,196
-13% -$122K
DIS icon
60
Walt Disney
DIS
$168B
$794K 0.4%
7,391
PFE icon
61
Pfizer
PFE
$141B
$730K 0.37%
21,261
-843
-4% -$28.7K
AOR icon
62
iShares Core 60/40 Balanced Allocation ETF
AOR
$3.64B
$716K 0.36%
15,952
-1,990
-11% -$90.4K
DUK icon
63
Duke Energy
DUK
$100B
$707K 0.35%
8,407
SYK icon
64
Stryker
SYK
$129B
$702K 0.35%
4,534
-100
-2% -$15.3K
IBM icon
65
IBM
IBM
$204B
$693K 0.35%
4,726
BXP icon
66
Boston Properties
BXP
$11B
$630K 0.32%
4,850
VEU icon
67
Vanguard FTSE All-World ex-US ETF
VEU
$65.9B
$585K 0.29%
10,699
-2,210
-17% -$119K
NEE icon
68
NextEra Energy
NEE
$185B
$568K 0.28%
14,560
IBB icon
69
iShares Biotechnology ETF
IBB
$9.44B
$529K 0.27%
+4,959
New +$530K
PAYX icon
70
Paychex
PAYX
$41.1B
$527K 0.26%
7,755
CAT icon
71
Caterpillar
CAT
$402B
$525K 0.26%
3,332
SYY icon
72
Sysco
SYY
$40.2B
$523K 0.26%
8,620
-300
-3% -$17K
BMY icon
73
Bristol-Myers Squibb
BMY
$128B
$485K 0.24%
7,930
-200
-2% -$12.5K
BA icon
74
Boeing
BA
$167B
$463K 0.23%
1,571
KMB icon
75
Kimberly-Clark
KMB
$37B
$455K 0.23%
3,775

Similar funds

Boston Research & Management's Q4 2017 Portfolio in Review

As of Q4 2017, Boston Research & Management held 98 positions worth $199M, up 1.9% from $196M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Boston Research & Management withdrew a net $8.84M in Q4 2017, closing 1 position and reducing 64 holdings. Its most notable exit was State Street Energy Select Sector SPDR ETF, an estimated $433K position sold in full.

By sector, the portfolio is most concentrated in Industrials at 15% of assets, down from 15% a quarter earlier, followed by Technology and Financials.

Against the trend, Boston Research & Management opened a new position in iShares Biotechnology ETF worth $529K.

  • Boston Research & Management's largest Q4 2017 buy was iShares Biotechnology ETF: 4,959 shares worth $529K.
  • Boston Research & Management added most to iShares Core S&P 500 ETF in Q4 2017, an estimated $582K increase.
  • Boston Research & Management's biggest Q4 2017 reduction was VanEck Biotech ETF, cutting an estimated $623K.
  • Boston Research & Management fully exited State Street Energy Select Sector SPDR ETF in Q4 2017, selling an estimated $433K.
  • Boston Research & Management's ten largest holdings make up 24% of its $199M portfolio in Q4 2017.
  • Boston Research & Management opened 2 new positions and closed 1 in Q4 2017.
  • Boston Research & Management's portfolio value rose 1.9% quarter-over-quarter to $199M.

Based on Boston Research & Management's 13F filing for Q4 2017, filed 9 Feb 2018.